Viloxazina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Viloxazina" in Italian language version.

refsWebsite

Global rank Italian rank

16nih.gov

4^th place

9^th place

7doi.org

2^nd place

7^th place

4oadoi.org

799^th place

22^nd place

12ch.net

low place

1web.archive.org

1^st place

1aspetjournals.org

6,663^rd place

5,217^th place

2ch.net

life7.2ch.net

【合法】個人輸入代行薬【未認可】 (The relevant section is English^{[senza fonte]})

aspetjournals.org

jpet.aspetjournals.org

Lloyd KG, Thuret F, Pilc A, Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock, in The Journal of Pharmacology and Experimental Therapeutics, vol. 235, n. 1, ottobre 1985, pp. 191–9, PMID 2995646.

doi.org

dx.doi.org

Müller-Oerlinghausen B, Rüther E, Clinical profile and serum concentration of viloxazine as compared to amitriptyline, in Pharmakopsychiatrie, Neuro-Psychopharmakologie, vol. 12, n. 4, luglio 1979, pp. 321–37, DOI:10.1055/s-0028-1094627, PMID 386390.
Mitler MM, Hajdukovic R, Erman M, Koziol JA, Narcolepsy, in Journal of Clinical Neurophysiology, vol. 7, n. 1, gennaio 1990, pp. 93–118, DOI:10.1097/00004691-199001000-00008, PMC 2254143, PMID 1968069.
Lippman W, Pugsley TA, Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities, in Canadian Journal of Physiology and Pharmacology, vol. 54, n. 4, agosto 1976, pp. 494–509, DOI:10.1139/y76-069, PMID 974878.
Edwards JG, Glen-Bott M, Does viloxazine have epileptogenic properties?, in Journal of Neurology, Neurosurgery, and Psychiatry, vol. 47, n. 9, settembre 1984, pp. 960–4, DOI:10.1136/jnnp.47.9.960, PMC 1027998, PMID 6434699.
Pisani F, Fazio A, Artesi C, et al., Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction, in Journal of Neurology, Neurosurgery, and Psychiatry, vol. 55, n. 2, febbraio 1992, pp. 126–7, DOI:10.1136/jnnp.55.2.126, PMC 488975, PMID 1538217.
Perault MC, Griesemann E, Bouquet S, Lavoisy J, Vandel B, A study of the interaction of viloxazine with theophylline, in Therapeutic Drug Monitoring, vol. 11, n. 5, settembre 1989, pp. 520–2, DOI:10.1097/00007691-198909000-00005, PMID 2815226.
Laaban JP, Dupeyron JP, Lafay M, Sofeir M, Rochemaure J, Fabiani P, Theophylline intoxication following viloxazine induced decrease in clearance, in European Journal of Clinical Pharmacology, vol. 30, n. 3, 1986, pp. 351–3, DOI:10.1007/BF00541543, PMID 3732375.

nih.gov

ncbi.nlm.nih.gov

Müller-Oerlinghausen B, Rüther E, Clinical profile and serum concentration of viloxazine as compared to amitriptyline, in Pharmakopsychiatrie, Neuro-Psychopharmakologie, vol. 12, n. 4, luglio 1979, pp. 321–37, DOI:10.1055/s-0028-1094627, PMID 386390.
(RU) Danchev ND, Rozhanets VV, Zhmurenko LA, Glozman OM, Zagorevskiĭ VA, Behavioral and radioreceptor analysis of viloxazine stereoisomers, in Biulleten' Eksperimental'noĭ Biologii i Meditsiny, vol. 97, n. 5, maggio 1984, pp. 576–8, PMID 6326891.
Attenburrow AA, Stanley TV, Holland RP, Nocturnal enuresis: a study, in The Practitioner, vol. 228, n. 1387, gennaio 1984, pp. 99–102, PMID 6364124.
Yurdakök M, Kinik E, Güvenç H, Bedük Y, Viloxazine versus imipramine in the treatment of enuresis, in The Turkish Journal of Pediatrics, vol. 29, n. 4, 1987, pp. 227–30, PMID 3332732.
(FR) Libert MH, The use of viloxazine in the treatment of primary enuresis, in Acta Urologica Belgica, vol. 58, n. 1, 1990, pp. 117–22, PMID 2371930.
Guilleminault C, Mancuso J, Salva MA, et al., Viloxazine hydrochloride in narcolepsy: a preliminary report, in Sleep, vol. 9, 1 Pt 2, 1986, pp. 275–9, PMID 3704453.
Mitler MM, Hajdukovic R, Erman M, Koziol JA, Narcolepsy, in Journal of Clinical Neurophysiology, vol. 7, n. 1, gennaio 1990, pp. 93–118, DOI:10.1097/00004691-199001000-00008, PMC 2254143, PMID 1968069.
Altamura AC, Mauri MC, Girardi T, Panetta B, Alcoholism and depression: a placebo controlled study with viloxazine, in International Journal of Clinical Pharmacology Research, vol. 10, n. 5, 1990, pp. 293–8, PMID 2079386.
(ES) León CA, Vigoya J, Conde S, Campo G, Castrillón E, León A, Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia, in Acta Psiquiátrica Y Psicológica de América Latina, vol. 40, n. 1, marzo 1994, pp. 41–9, PMID 8053353.
Lippman W, Pugsley TA, Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities, in Canadian Journal of Physiology and Pharmacology, vol. 54, n. 4, agosto 1976, pp. 494–509, DOI:10.1139/y76-069, PMID 974878.
Lloyd KG, Thuret F, Pilc A, Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock, in The Journal of Pharmacology and Experimental Therapeutics, vol. 235, n. 1, ottobre 1985, pp. 191–9, PMID 2995646.
(FR) Chebili S, Abaoub A, Mezouane B, Le Goff JF, Antidepressants and sexual stimulation: the correlation, in L'Encéphale, vol. 24, n. 3, 1998, pp. 180–4, PMID 9696909.
Edwards JG, Glen-Bott M, Does viloxazine have epileptogenic properties?, in Journal of Neurology, Neurosurgery, and Psychiatry, vol. 47, n. 9, settembre 1984, pp. 960–4, DOI:10.1136/jnnp.47.9.960, PMC 1027998, PMID 6434699.
Pisani F, Fazio A, Artesi C, et al., Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction, in Journal of Neurology, Neurosurgery, and Psychiatry, vol. 55, n. 2, febbraio 1992, pp. 126–7, DOI:10.1136/jnnp.55.2.126, PMC 488975, PMID 1538217.
Perault MC, Griesemann E, Bouquet S, Lavoisy J, Vandel B, A study of the interaction of viloxazine with theophylline, in Therapeutic Drug Monitoring, vol. 11, n. 5, settembre 1989, pp. 520–2, DOI:10.1097/00007691-198909000-00005, PMID 2815226.
Laaban JP, Dupeyron JP, Lafay M, Sofeir M, Rochemaure J, Fabiani P, Theophylline intoxication following viloxazine induced decrease in clearance, in European Journal of Clinical Pharmacology, vol. 30, n. 3, 1986, pp. 351–3, DOI:10.1007/BF00541543, PMID 3732375.

oadoi.org

Müller-Oerlinghausen B, Rüther E, Clinical profile and serum concentration of viloxazine as compared to amitriptyline, in Pharmakopsychiatrie, Neuro-Psychopharmakologie, vol. 12, n. 4, luglio 1979, pp. 321–37, DOI:10.1055/s-0028-1094627, PMID 386390.
Lippman W, Pugsley TA, Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities, in Canadian Journal of Physiology and Pharmacology, vol. 54, n. 4, agosto 1976, pp. 494–509, DOI:10.1139/y76-069, PMID 974878.
Perault MC, Griesemann E, Bouquet S, Lavoisy J, Vandel B, A study of the interaction of viloxazine with theophylline, in Therapeutic Drug Monitoring, vol. 11, n. 5, settembre 1989, pp. 520–2, DOI:10.1097/00007691-198909000-00005, PMID 2815226.
Laaban JP, Dupeyron JP, Lafay M, Sofeir M, Rochemaure J, Fabiani P, Theophylline intoxication following viloxazine induced decrease in clearance, in European Journal of Clinical Pharmacology, vol. 30, n. 3, 1986, pp. 351–3, DOI:10.1007/BF00541543, PMID 3732375.

web.archive.org

AstraZeneca International, Vivalan (viloxazine hydrochloride), su astrazeneca.com, 2003. URL consultato il 6 novembre 2005 (archiviato dall'url originale il 10 dicembre 2005).